{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:33:24Z","timestamp":1790721204147,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":2187,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.14283\/jpad.2018.35","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T07:33:17Z","timestamp":1614324797000},"page":"245-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Clinical Application of APOE in Alzheimer's Prevention: A Precision Medicine Approach"],"prefix":"10.1016","volume":"5","author":[{"given":"C.L.","family":"Berkowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mosconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Scheyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hristov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Isaacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.14283\/jpad.2018.35_bib1","volume":"2","year":"2012","journal-title":"Epidemiology of Alzheimer disease"},{"issue":"3","key":"10.14283\/jpad.2018.35_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging\u2013Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"10113","key":"10.14283\/jpad.2018.35_bib3","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"10.14283\/jpad.2018.35_bib4","first-page":"41","article-title":"Genetics of Alzheimer's disease","volume":"25\u201326","author":"Burke","year":"1991","journal-title":"Int J Neurol"},{"key":"10.14283\/jpad.2018.35_bib5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.14283\/jpad.2018.35_bib6","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.14283\/jpad.2018.35_bib7","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(94)92557-7","article-title":"Protection against Alzheimer's disease with apoE epsilon 2","author":"Talbot","year":"1994","journal-title":"Lancet"},{"issue":"16","key":"10.14283\/jpad.2018.35_bib8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta\u2013analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"Jama"},{"issue":"9","key":"10.14283\/jpad.2018.35_bib9","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopsych.2004.07.021","article-title":"Cerebrospinal fluid beta\u2013amyloid1\u201342 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele","volume":"56","author":"Sunderland","year":"2004","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.14283\/jpad.2018.35_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ana.22096","article-title":"Exercise and Alzheimer's disease biomarkers in cognitively normal older adults","volume":"68","author":"Liang","year":"2010","journal-title":"Ann Neurol"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE Predicts A\u03b2 but not Tau Alzheimer's Pathology in Cognitively Normal Aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann Neurol"},{"issue":"5","key":"10.14283\/jpad.2018.35_bib12","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archneurol.2011.845","article-title":"Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition","volume":"69","author":"Head","year":"2012","journal-title":"Arch Neurol"},{"issue":"2","key":"10.14283\/jpad.2018.35_bib13","first-page":"195","article-title":"Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease","volume":"67","author":"Kamboh","year":"1995","journal-title":"Hum Biol"},{"issue":"6","key":"10.14283\/jpad.2018.35_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jalz.2012.09.012","article-title":"The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress","volume":"9","author":"Kivipelto","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.14283\/jpad.2018.35_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2017.09.006","article-title":"Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial","volume":"14","author":"Rosenberg","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2018.35_bib16","article-title":"Effect of the Apolipoprotein E^Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A^Subgroup Analysis of a Randomized Clinical Trial","author":"Solomon","year":"2018","journal-title":"JAMA^Neurol"},{"issue":"6","key":"10.14283\/jpad.2018.35_bib17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1037\/0278-6133.25.6.678","article-title":"Physical activity and cognitive function in a cross\u2013section of younger and older community\u2013dwelling individuals","volume":"25","author":"Hillman","year":"2006","journal-title":"Health Psychol"},{"key":"10.14283\/jpad.2018.35_bib18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.dadm.2018.01.001","article-title":"Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer's disease","volume":"10","author":"Law","year":"2018","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/S0033291708003681","article-title":"Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence","volume":"39","author":"Hamer","year":"2009","journal-title":"Psychol Med"},{"key":"10.14283\/jpad.2018.35_bib20","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1111\/j.1582-4934.2008.00296.x","article-title":"Apolipoprotein E \u03b54 magnifies lifestyle risks for dementia: a population\u2013based study","author":"Kivipelto","year":"2008","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1249\/01.mss.0000239399.85955.5e","article-title":"Cognitive performance in older women relative to ApoEepsilon4 genotype and aerobic fitness","volume":"39","author":"Etnier","year":"2007","journal-title":"Med Sci Sports Exerc"},{"key":"10.14283\/jpad.2018.35_bib22","article-title":"Physical activity and amyloid\u2013\u03b2 plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing","author":"Brown","year":"2012","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.neuroimage.2010.07.070","article-title":"Interactive Effects of Physical Activity and APOE\u2013\u03b54 on BOLD^Semantic Memory Activation in Healthy Elders","volume":"54","author":"Smith","year":"2011","journal-title":"Neuroimage"},{"issue":"9","key":"10.14283\/jpad.2018.35_bib24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jama.300.9.1027","article-title":"Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial","volume":"300","author":"Lautenschlager","year":"2008","journal-title":"Jama"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1360-0443.2002.00016.x","article-title":"Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case\u2013control and cohort studies","volume":"97","author":"Almeida","year":"2002","journal-title":"Addiction"},{"issue":"2","key":"10.14283\/jpad.2018.35_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ntr\/ntv075","article-title":"Interaction of Cigarette Smoking History With APOE^Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders","volume":"18","author":"Durazzo","year":"2016","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"10.14283\/jpad.2018.35_bib27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3233\/JAD-2010-1399","article-title":"Isolated and joint effects of tobacco and alcohol consumption on risk of Alzheimer's disease","volume":"20","author":"Garcia","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"10.14283\/jpad.2018.35_bib28","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/JGP.0b013e3181a2fd07","article-title":"Alcohol consumption as a risk factor for dementia and cognitive decline: meta\u2013analysis of prospective studies","volume":"17","author":"Anstey","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"issue":"11","key":"10.14283\/jpad.2018.35_bib29","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jama.289.11.1405","article-title":"Prospective study of alcohol consumption and risk of dementia in older adults","volume":"289","author":"Mukamal","year":"2003","journal-title":"Jama"},{"issue":"4","key":"10.14283\/jpad.2018.35_bib30","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1532-5415.2004.52159.x","article-title":"Alcohol intake and risk of dementia","volume":"52","author":"Luchsinger","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.14283\/jpad.2018.35_bib31","first-page":"17","author":"Downer","year":"2014","journal-title":"The Relationship Between Midlife and Late Life Alcohol Consumption, APOE e4 and the Decline in Learning and Memory Among Older Adults"},{"key":"10.14283\/jpad.2018.35_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.38181.418958.BE","article-title":"Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study","author":"Anttila","year":"2004","journal-title":"Bmj"},{"issue":"3","key":"10.14283\/jpad.2018.35_bib33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamaneurol.2016.3822","article-title":"Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE \u03b54 Genotype","volume":"74","author":"Krell\u2013Roesch","year":"2018","journal-title":"JAMA Neurology"},{"issue":"12","key":"10.14283\/jpad.2018.35_bib34","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1212\/01.WNL.0000036905.59156.A1","article-title":"Cognitive activity and incident AD in a population\u2013based sample of older persons","volume":"59","author":"Wilson","year":"2002","journal-title":"Neurology"},{"issue":"6","key":"10.14283\/jpad.2018.35_bib35","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jama.287.6.742","article-title":"Participation in cognitively stimulating activities and risk of incident Alzheimer disease","volume":"287","author":"Wilson","year":"2002","journal-title":"Jama"},{"issue":"2","key":"10.14283\/jpad.2018.35_bib36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1017\/S1041610207006655","article-title":"Physical, social and productive leisure activities, cognitive decline and interaction with APOE\u2013epsilon 4 genotype in Chinese older adults","volume":"20","author":"Niti","year":"2008","journal-title":"Int Psychogeriatr"},{"issue":"5","key":"10.14283\/jpad.2018.35_bib37","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jalz.2008.07.002","article-title":"Midlife activity predicts risk of dementia in older male twin pairs","volume":"4","author":"Carlson","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2018.35_bib38","doi-asserted-by":"crossref","first-page":"8612","DOI":"10.1523\/JNEUROSCI.4612-13.2014","article-title":"Gene\u2013Environment Interactions: Lifetime Cognitive Activity, APOE Genotype, and Beta\u2013Amyloid Burden","author":"Wirth","year":"2014","journal-title":"in J Neurosci"},{"issue":"4","key":"10.14283\/jpad.2018.35_bib39","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2174\/156720512800492477","article-title":"Lifestyle and genetic contributions to cognitive decline and hippocampal structure and function in healthy aging","volume":"9","author":"Woodard","year":"2012","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib40","first-page":"23","article-title":"Mediterranean Diet and Magnetic Resonance Imaging\u2013Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Disease","volume":"1","author":"Mosconi","year":"2014","journal-title":"J Prev Alzheimers Dis"},{"issue":"2","key":"10.14283\/jpad.2018.35_bib41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3233\/JAD-130830","article-title":"Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta\u2013analysis","volume":"39","author":"Singh","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.14283\/jpad.2018.35_bib42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12263-014-0393-7","article-title":"Genotype patterns at CLU, CR1, PICALM and APOE, cognition and Mediterranean diet: the PREDIMED\u2013NAVARRA trial","volume":"9","author":"Martinez\u2013Lapiscina","year":"2014","journal-title":"Genes Nutr"},{"issue":"2","key":"10.14283\/jpad.2018.35_bib43","first-page":"137","article-title":"Adherence to the Mediterranean Diet Is not Related to Beta\u2013Amyloid Deposition: Data from the Women's Healthy Ageing Project","volume":"5","author":"Hill","year":"2018","journal-title":"J Prev Alzheimers Dis"},{"issue":"7","key":"10.14283\/jpad.2018.35_bib44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/gps.1969","article-title":"Fat intake at midlife and cognitive impairment later in life: a population\u2013based CAIDE study","volume":"23","author":"Eskelinen","year":"2008","journal-title":"Int J^Geriatr Psychiatry"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000093478","article-title":"Fat Intake at Midlife and Risk of Dementia and Alzheimer's Disease: A Population\u2013Based Study","volume":"22","author":"Laitinen","year":"2018","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/JAD-150273","article-title":"Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E varepsilon4 Carriers and Adults with Mild Cognitive Impairment","volume":"48","author":"Hanson","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.14283\/jpad.2018.35_bib48","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3233\/JAD-150886","article-title":"Impact of Omega\u20133 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults","volume":"51","author":"Kulzow","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.14283\/jpad.2018.35_bib49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/jamaneurol.2016.4899","article-title":"Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E \u03b54 Carriers: A Review","volume":"74","author":"Yassine","year":"2018","journal-title":"JAMA Neurology"},{"issue":"5","key":"10.14283\/jpad.2018.35_bib50","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3945\/ajcn.112.053371","article-title":"DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial","volume":"97","author":"Stonehouse","year":"2013","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.14283\/jpad.2018.35_bib51","first-page":"292","article-title":"MAPT (Multi\u2013Domain Alzheimer's Prevention Trial): clinical biomarkers, results and lessons for the future [abstract OC33]","volume":"2","author":"Vellas","year":"2015","journal-title":"J Prev Alzheimers Dis"},{"issue":"6","key":"10.14283\/jpad.2018.35_bib52","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1212\/01.wnl.0000324268.45138.86","article-title":"Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial","volume":"71","author":"van de Rest","year":"2008","journal-title":"Neurology"},{"issue":"9","key":"10.14283\/jpad.2018.35_bib53","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1212\/01.wnl.0000183148.34197.2e","article-title":"Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4","volume":"65","author":"Huang","year":"2005","journal-title":"Neurology"},{"issue":"17","key":"10.14283\/jpad.2018.35_bib54","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial","volume":"304","author":"Quinn","year":"2010","journal-title":"Jama"},{"key":"10.14283\/jpad.2018.35_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2014.10.003","article-title":"The benefit of docosahexaenoic acid for the adult brain in aging and dementia. Prostaglandins","author":"Salem","year":"2015","journal-title":"Leukotrienes and Essential Fatty Acids (PLEFA)"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1017\/S0029665107005307","article-title":"The impact of EPA and DHA on blood lipids and lipoprotein metabolism: influence of apoE genotype","volume":"66","author":"Anil","year":"2007","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib57","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.atherosclerosis.2009.08.024","article-title":"Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL\u2013cholesterol response to fish oil","volume":"209","author":"Olano\u2013Martin","year":"2010","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.14283\/jpad.2018.35_bib58","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000339702","article-title":"Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta\u2013analysis","volume":"33","author":"Etgen","year":"2012","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"5","key":"10.14283\/jpad.2018.35_bib59","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1017\/S0007114513003176","article-title":"25\u2013Hydroxyvitamin D and cognitive performance in midlife","volume":"111","author":"Maddock","year":"2014","journal-title":"Br J Nutr"},{"issue":"4","key":"10.14283\/jpad.2018.35_bib60","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ejcn.2014.201","article-title":"25\u2013Hydroxyvitamin D,^APOE \u03b54 genotype and cognitive function: findings from the 1958 British birth cohort","volume":"69","author":"Maddock","year":"2015","journal-title":"European journal of clinical nutrition"},{"issue":"3","key":"10.14283\/jpad.2018.35_bib61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/aje\/153.3.225","article-title":"Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication?","volume":"153","author":"Guo","year":"2001","journal-title":"Am J^Epidemiol"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1212\/01.wnl.0000284596.95156.48","article-title":"NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type","volume":"70","author":"Szekely","year":"2008","journal-title":"Neurology"},{"key":"10.14283\/jpad.2018.35_bib63","first-page":"2","article-title":"Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?","author":"Imbimbo","year":"2010","journal-title":"Front Aging Neurosci"},{"key":"10.14283\/jpad.2018.35_bib64","author":"Drye","year":"2012","journal-title":"Role of APOE and Age at Enrollment in the Alzheimer's Disease Anti\u2013Inflammatory Prevention Trial (ADAPT), in Dement Geriatr Cogn Dis Extra"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib67","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jama.282.1.40","article-title":"The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons","volume":"282","author":"Haan","year":"1999","journal-title":"Jama"},{"key":"10.14283\/jpad.2018.35_bib68","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-017-0262-x","article-title":"Association between blood pressure and Alzheimer disease measured up to 27 years prior to diagnosis: the HUNT^Study","author":"Gabin","year":"2017","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"10.14283\/jpad.2018.35_bib69","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archneur.58.10.1640","article-title":"Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study","volume":"58","author":"Morris","year":"2001","journal-title":"Arch Neurol"},{"key":"10.14283\/jpad.2018.35_bib70","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","article-title":"15\u2013year longitudinal study of blood pressure and dementia","author":"Skoog","year":"1996","journal-title":"Lancet"},{"issue":"5","key":"10.14283\/jpad.2018.35_bib71","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.61.5.655","article-title":"Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD","volume":"61","author":"Qiu","year":"2003","journal-title":"Neurology"},{"key":"10.14283\/jpad.2018.35_bib72","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study","author":"Kivipelto","year":"2001","journal-title":"Bmj"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib73","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0197-4580(00)00096-8","article-title":"Midlife blood pressure and dementia: the Honolulu\u2013Asia aging study","volume":"21","author":"Launer","year":"2000","journal-title":"Neurobiol Aging"},{"issue":"12","key":"10.14283\/jpad.2018.35_bib74","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1161\/hs1201.100392","article-title":"Joint effect of the APOE gene and midlife systolic blood pressure on late\u2013life cognitive impairment: the Honolulu\u2013Asia aging study","volume":"32","author":"Peila","year":"2001","journal-title":"Stroke"},{"issue":"5","key":"10.14283\/jpad.2018.35_bib75","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1001\/jamaneurol.2013.1342","article-title":"Risk factors for beta\u2013amyloid deposition in healthy aging: vascular and genetic effects","volume":"70","author":"Rodrigue","year":"2013","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.14283\/jpad.2018.35_bib76","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1590\/1980-57642016dn11-020002","article-title":"Type 2 diabetes mellitus in the pathophysiology of Alzheimer's disease","volume":"11","author":"de Nazareth","year":"2017","journal-title":"Dement Neuropsychol"},{"key":"10.14283\/jpad.2018.35_bib77","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/epirev\/mxs012","article-title":"Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship","author":"Vagelatos","year":"2013","journal-title":"Epidemiol Rev"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib78","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archneurol.2007.29","article-title":"Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study","volume":"65","author":"Irie","year":"2008","journal-title":"Arch Neurol"},{"issue":"4","key":"10.14283\/jpad.2018.35_bib79","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes,^APOE gene, and the risk for dementia and related pathologies: The Honolulu\u2013Asia Aging Study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"issue":"3","key":"10.14283\/jpad.2018.35_bib80","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neurobiolaging.2004.04.010","article-title":"Developmental and vascular risk factors for Alzheimer's disease","volume":"26","author":"Borenstein","year":"2005","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib81","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000231980","article-title":"Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later","volume":"28","author":"Solomon","year":"2009","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"10.14283\/jpad.2018.35_bib82","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-2275(20)41611-6","article-title":"Modulation of plasma triglyceride levels by apoE phenotype: a meta\u2013analysis","volume":"33","author":"Dallongeville","year":"1992","journal-title":"J Lipid Res"},{"issue":"3","key":"10.14283\/jpad.2018.35_bib83","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3945\/ajcn.116.135012","article-title":"The effect of the apolipoprotein E genotype on response to personalized dietary advice intervention: findings from the Food4Me randomized controlled trial","volume":"104","author":"Fallaize","year":"2016","journal-title":"Am J^Clin Nutr"},{"key":"10.14283\/jpad.2018.35_bib84","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ije\/dyt034","article-title":"Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: Systematic review and meta\u2013analysis of 14 015 stroke cases and pooled analysis of primary biomarker data from up to 60 883 individuals","author":"Khan","year":"2013","journal-title":"in Int J^Epidemiol"},{"issue":"9","key":"10.14283\/jpad.2018.35_bib85","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/01.WNL.0000160114.42643.31","article-title":"APOE genotype, cholesterol level, lipid\u2013lowering treatment, and dementia: the Three\u2013City Study","volume":"64","author":"Dufouil","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib86","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/WNL.54.1.240","article-title":"Serum cholesterol,^APOE genotype, and the risk of Alzheimer's disease: a population\u2013based study of African Americans","volume":"54","author":"Evans","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.14283\/jpad.2018.35_bib87","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1212\/01.wnl.0000194507.39504.17","article-title":"Cholesterol,^APOE genotype, and Alzheimer disease: An epidemiologic study of Nigerian Yoruba","volume":"66","author":"Hall","year":"2006","journal-title":"Neurology"},{"issue":"17","key":"10.14283\/jpad.2018.35_bib88","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/jama.1994.03510410028015","article-title":"Alzheimer's disease, apolipoprotein E4, and gender","volume":"271","author":"Payami","year":"1994","journal-title":"Jama"},{"issue":"4","key":"10.14283\/jpad.2018.35_bib89","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.24135","article-title":"Sex modifies the APOE\u2013related risk of developing Alzheimer disease","volume":"75","author":"Altmann","year":"2014","journal-title":"Ann Neurol"},{"issue":"29","key":"10.14283\/jpad.2018.35_bib90","doi-asserted-by":"crossref","first-page":"26663","DOI":"10.18632\/oncotarget.5185","article-title":"APOE\u2013by\u2013sex interactions on brain structure and metabolism in healthy elderly controls","volume":"6","author":"Sampedro","year":"2015","journal-title":"Oncotarget"},{"issue":"10","key":"10.14283\/jpad.2018.35_bib91","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaneurol.2017.2188","article-title":"Apolipoprotein E^Genotype and Sex Risk Factors for Alzheimer Disease: A^Meta\u2013analysis","volume":"74","author":"Neu","year":"2017","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.14283\/jpad.2018.35_bib92","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/WAD.0b013e31815a9dcc","article-title":"Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL^Study","volume":"22","author":"Chao","year":"2008","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.14283\/jpad.2018.35_bib93","article-title":"Accelerating precision health by applying the lessons learned from directto\u2013consumer genomics to digital health technologies. NAM^Perspectives","author":"Tung","year":"2018","journal-title":"Discussion Paper"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724005090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724005090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:52:33Z","timestamp":1736470353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724005090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2274580724005090"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2018.35","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Application of APOE in Alzheimer's Prevention: A Precision Medicine Approach","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2018.35","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}